legal papers image


Kratom has long existed in a regulatory gray area. In 2016, the U.S. Drug Enforcement Administration announced plans to classify kratom as a Schedule I Controlled Substance. However, kratom advocates, lawmakers, and scientists appealed to the DEA and ultimately prevented scheduling kratom as an illicit substance.

The Kratom Foundation supports maintaining the federal legal status of kratom. However, as a not-for-profit 501(c)3 organization, we do not lobby for any cause or law.


Currently, kratom is not approved for use by the U.S. Food and Drug Administration and is thus unregulated by the federal government or other regulatory bodies. Unfortunately, the lack of regulation has resulted in documented harm caused by kratom supplements produced with poor manufacturing practices.

The Kratom Foundation aims to improve the safety of kratom by helping producers learn about current Good Manufacturing Practice (cGMP) and achieve compliance.

FDA lab testing


Serious and life-threatening adverse events related to kratom have been reported to the FDA by consumers and physicians. Also, contamination of kratom products with heavy metals and bacterial byproducts has caused illness, demonstrating the need to establish manufacturing standards and third-party oversight to ensure standardized and safe kratom production.

The Kratom Foundation aims to help establish GMP manufacturing practices to attenuate health risks caused by adulteration and contamination with illicit substances and infectious pathogens. Furthermore, educating consumers and physicians about reported kratom-related adverse events will allow for more informed joint decision-making on kratom use.